377 results
8-K
EX-99.1
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
4:10pm
statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded
8-K
EX-99.2
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
4:10pm
provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as “believes,” “expects
8-K
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
4:10pm
are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may involve risks
8-K
EX-1.1
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
4:10pm
agreements may be limited by federal or state securities Laws or public policy considerations in respect thereof.
(s) No Litigation. Except as set … such Governmental Authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has
424B5
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Prospectus supplement for primary offering
4:09pm
contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking … rights and our ability to avoid intellectual property litigation, which can be costly and divert management time and attention;
our ability to develop
424B5
ryuk6z
28 Feb 24
Prospectus supplement for primary offering
4:10pm
424B5
em2x8tz0qp
26 Feb 24
Prospectus supplement for primary offering
8:18am
8-K
EX-99.1
5ur0l07
26 Feb 24
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
7:01am
8-K
tzwacwu5
8 Nov 23
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
8-K
EX-99.2
63bpm n3n0z6yxf8
8 Nov 23
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
8-K
EX-1.1
fj8cqirvi77
8 Nov 23
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
8-K
EX-99.1
xw59tey pdq2hd
8 Nov 23
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
424B5
x5kdbezyvg83jrzb1
8 Nov 23
Prospectus supplement for primary offering
5:01pm
424B5
9txjph kehktupsi9
7 Nov 23
Prospectus supplement for primary offering
4:01pm
8-K
299iyp4z
6 Nov 23
Other Events
9:00am
8-K
EX-99.1
ree2sts
2 Nov 23
Celldex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:01pm